Literature DB >> 8106358

Arrestin-rhodopsin interaction. Multi-site binding delineated by peptide inhibition.

J G Krupnick1, V V Gurevich, T Schepers, H E Hamm, J L Benovic.   

Abstract

Visual arrestin modulates the intracellular response of retinal rod cells to light by specifically binding to the phosphorylated light-activated form of the photoreceptor rhodopsin (P-Rh*). In order to characterize the molecular interaction between rhodopsin and arrestin, we have studied the ability of synthetic peptides from the proposed cytoplasmic loops of rhodopsin to inhibit arrestin binding. A third cytoplasmic loop peptide competed most effectively for arrestin binding to P-Rh*, exhibiting an IC50 of 34 microM, while a first cytoplasmic loop peptide weakly inhibited binding with an IC50 of approximately 1100 microM. The first and third cytoplasmic loop peptides also inhibited P-Rh* interaction with both ARR[delta (2-16)-404], an arrestin mutant that lacks residues 2-16, and ARR[1-191], a mutant that contains only the amino half of arrestin. However, the third loop peptide had an approximately 5-fold lower affinity at inhibiting the binding of ARR[1-191] to P-Rh*. While the first and third loop peptides also inhibited arrestin binding to light-activated rhodopsin and a truncated rhodopsin lacking its C-terminal sites of phosphorylation, the peptides modestly enhanced arrestin binding to phosphorylated dark rhodopsin. These results suggest that the third and, to a lesser extent, the first cytoplasmic loops of rhodopsin may play an important role in arrestin binding to light-activated forms of rhodopsin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106358

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Site-directed mutagenesis of highly conserved amino acids in the first cytoplasmic loop of Drosophila Rh1 opsin blocks rhodopsin synthesis in the nascent state.

Authors:  J Bentrop; K Schwab; W L Pak; R Paulsen
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

Review 2.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

3.  Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin.

Authors:  Susan M Hanson; Derek J Francis; Sergey A Vishnivetskiy; Elena A Kolobova; Wayne L Hubbell; Candice S Klug; Vsevolod V Gurevich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-17       Impact factor: 11.205

4.  Ant opsins: sequences from the Saharan silver ant and the carpenter ant.

Authors:  M P Popp; R Grisshammer; P A Hargrave; W C Smith
Journal:  Invert Neurosci       Date:  1996-03

Review 5.  Structure and functions of arrestins.

Authors:  K Palczewski
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

6.  Formation of a ternary complex among NHERF1, beta-arrestin, and parathyroid hormone receptor.

Authors:  Christoph Klenk; Thorsten Vetter; Alexander Zürn; Jean-Pierre Vilardaga; Peter A Friedman; Bin Wang; Martin J Lohse
Journal:  J Biol Chem       Date:  2010-07-23       Impact factor: 5.157

7.  Regulation of sorting and post-Golgi trafficking of rhodopsin by its C-terminal sequence QVS(A)PA.

Authors:  D Deretic; S Schmerl; P A Hargrave; A Arendt; J H McDowell
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Topographic study of arrestin using differential chemical modifications and hydrogen/deuterium exchange.

Authors:  H Ohguro; K Palczewski; K A Walsh; R S Johnson
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

9.  An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.

Authors:  Hongxiang Lan; Martha M Teeter; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2008-09-26       Impact factor: 4.436

10.  Targeting individual GPCRs with redesigned nonvisual arrestins.

Authors:  Luis E Gimenez; Sergey A Vishnivetskiy; Vsevolod V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.